乙型肝炎病毒携带者

抑制消减杂交法筛选无症状乙型肝炎病毒携带者差异表达基因

Screening differentially expressed genes of asymptomatic HBV carriers by suppression subtracted hybridization

220例慢性乙型肝炎病毒携带者病理特点及5年随访

Morphological features and five year follow-up study of 220 chronic HBV carriers

乙型肝炎病毒携带者精子中HBVdna的检测及意义

Significance and detection of HBV DNA in spermatozoa with hepatitis B virus carriers

乙型肝炎病毒携带者HBV血清标志物转归分析

Analysis on Conversion Pattern of HBV Markers in the Carriers of Hepatitis B Virus

乙型肝炎病毒携带者与ABO血型关系的探讨

Investigation of the Correlation between HBV Carriers and ABO Blood Type

慢性乙型肝炎病毒携带者血清IL-1I、L-6和CRP水平与肝组织学相关研究

Study on relationship between level of serum IL-1 , IL-6 , CRP and change of hepatic pathology in chronic HBV carriers

目的输血传播病毒（TTV）在中国郑州地区乙型肝炎病毒携带者、乙型肝炎患者中的感染情况。

Objective To investigate the prevalence of TTV infection in hepatitis B patients and HBV carriers .

乙型肝炎病毒携带者HBV-DNA含量明显高于慢性乙型肝炎。

The HBV-DNA level in HBV health carriers was significantly higher than that in patients with chronic Hepatitis B .

结论与CsA相比，乙型肝炎病毒携带者肾移植术后应用FK506可降低肝功能损害的发生率，减少乙型肝炎复发。

Conclusion Compared with CsA , FK506 can significantly lower the incidence of liver function injury after kidney transplantation for HBV carriers , and reduce Hepatitis B recurrent rate .

目的：探讨母婴传播的慢性无症状乙型肝炎病毒携带者（ASC）病程的变化情况及乙肝病毒血清标志物（HBVM）的表达。

Objective Discussing the develop of The chronic asymptomatic HBV carrier ( ASC ) from the mother to infants transmission , and discuss the exhibition of the Hepatitis B Virus Serum Sign Matter ( HBVM ) .

乙型肝炎病毒携带者的肝脏病理学特点

Liver histopathological features of chronic HBV carriers and inactive HBsAg carriers

534例乙型肝炎病毒携带者随访结果分析

Analyse the results of follow - investigating the 534 of HBV carrier

非活动期乙型肝炎病毒携带者淋巴组织中乙型肝炎病毒的感染

Hepatitis B virus infection in lymphatic tissues in inactive hepatitis B carriers

慢性无症状乙型肝炎病毒携带者的基因型研究

The distribution of genotypes in chronic asymptomatic hepatitis B virus carriers in Huangshi

乙型肝炎病毒携带者丁型肝炎病毒混合感染的血清流行病学调查

Seroepidemiological investigation on polyinfection of HDV in HBV carrier

我国乙型肝炎病毒携带者健康权现状分析

Status Analysis of the Right to Health of Hepatitis B Virus Carriers in China

乙型肝炎病毒携带者的家庭护理

Family Nursing of Carriers of Hepatitis Virus B

乙型肝炎病毒携带者；预防接种；

Hepatitis B viral carrier Preventive vaccination ;

乙型肝炎病毒携带者T细胞亚群检测及其与肝组织病变程度的关系

The relationship between the T lymphocyte subsets expression and pathological changes in liver tissues in HBV carriers

乙型肝炎病毒携带者肾移植后应用他克莫司和环孢素A对肝功能影响的比较

The effect on liver function after kidney transplantation of HBV carriers : comparison between tacrolimus and cyclosporin A

由于乙型肝炎病毒携带者肝组织已存在不同程度的损害，比非乙型肝炎病毒感染者更容易发生药物性肝炎。

As the liver tissue in the hepatitis B virus carrier has different degree injury , they get hepatitis of drug more easier .

因此，非肝病治疗药物导致慢性乙型肝炎病毒携带者肝损害应引起高度重视。

Therefore , it should be highly appreciated that drugs of non-therapy for hepatic diseases reduce to hepatic injury in chronic hepatitis B virus carrier .

目的通过对健康人群（非新生儿）乙肝疫苗接种等知识的调查，寻找降低乙型肝炎病毒携带者发病率的最有效方法。

Objective To find a effective way in reducing HBV - carrying incidence through survey of the knowledge concerning hepatitis B vaccination in the health population .

我们知道，全世界乙型肝炎病毒携带者大约有2.8亿，其中我国约占到一半。

As we know , the hepatitis B virus carriers more than 280 million all over the world , the numbers accounts for about half in China .

全世界大约有3亿5千万乙型肝炎病毒携带者，这种感染者集中分布于东南亚、东亚及非洲的撒哈拉地区。

There are approximately 350 million chronic carriers of hepatitis B virus ( HBV ) throughout the world . The infection is endemic to several populous regions of the world that include south east and east Asia , the western Pacific islands and sub-Saharan Africa .

正常人与乙型肝炎病毒慢性携带者中乙型肝炎疫苗的血清学效果的观察

Serological Effect of Hepatitis B Vaccine on Healthy Persons and Chronic Hepatitis B Virus Carriers

无症状乙型肝炎病毒表面抗原携带者血清HBV复制指标的检测

Detection of the HBV Replicative Markers in Serum of Asymptomatic HBsAg Carriers

结论血清ADA水平是反映肝细胞损害的一个良好指标，乙型肝炎病毒患者或携带者血清ADA在一定程度上反映HBV的复制情况，其水平测定对指导临床治疗有重要意义。

Conclusions The serum ADA level of hepatitis B virus infected patient can be used as an index of treatment effectiveness evaluation , and it is of great value to working out the effective healing solution .

乙型肝炎病毒表面抗原携带者队列前瞻性研究在肝癌发生发展中的意义

Significance of prospective follow-up cohort study in diagnosis and treatment of primary hepatic cancer among HBsAg carriers

慢性乙型肝炎患者或病毒携带者是发展为肝硬化和肝细胞癌的危险因素，15%~25%的感染者或携带者最终将死于与乙肝病毒感染相关的疾病。

Chronic hepatitis B patient or carrier is the risk factor of liver cirrhosis and hepatic cellular cancer . About 15 percent to 25 percent chronic hepatitis B patients or carriers will succumb to diseases which correlate to hepatitis B virus infection at the last .